Luis C. Lima

Porto, 4200072, Portugal

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 42 publications

A preliminary assessment of a stool-based microRNA profile for early colorectal cancer screening.

A preliminary assessment of a stool-based microRNA profile for early colorectal cancer screening.

Journal: Scientific reports

Published: March 27, 2025

Advancing Non-Invasive Colorectal Cancer Screening: Exploring the Potential of Monoclonal Antibody L2A5.

Advancing Non-Invasive Colorectal Cancer Screening: Exploring the Potential of Monoclonal Antibody L2A5.

Journal: International journal of molecular sciences

Published: February 05, 2025

Exosome-derived hsa-miR-200c-3p, hsa-miR-25-3p and hsa-miR-301a-3p as potential biomarkers and therapeutic targets for restoration of PTEN expression in clear cell renal cell carcinoma.

Exosome-derived hsa-miR-200c-3p, hsa-miR-25-3p and hsa-miR-301a-3p as potential biomarkers and therapeutic targets for restoration of PTEN expression in clear cell renal cell carcinoma.

Journal: International journal of biological macromolecules

Published: January 07, 2025

ABCB1 C1236T, G2677TA and C3435T Genetic Polymorphisms and Antidepressant Response Phenotypes: Results from a Portuguese Major Depressive Disorder Cohort.

ABCB1 C1236T, G2677TA and C3435T Genetic Polymorphisms and Antidepressant Response Phenotypes: Results from a Portuguese Major Depressive Disorder Cohort.

Journal: International journal of molecular sciences

Published: March 20, 2024

Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer.

Stool Glycoproteomics Signatures of Pre-Cancerous Lesions and Colorectal Cancer.

Journal: International journal of molecular sciences

Published: March 01, 2024

Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.

Aberrantly Glycosylated GLUT1 as a Poor Prognosis Marker in Aggressive Bladder Cancer.

Journal: International journal of molecular sciences

Published: February 12, 2024

Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells.

Multilevel plasticity and altered glycosylation drive aggressiveness in hypoxic and glucose-deprived bladder cancer cells.

Journal: iScience

Published: November 27, 2023

Minimizing false positives for CTC identification.

Minimizing false positives for CTC identification.

Journal: Analytica chimica acta

Published: October 12, 2023

MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.

MicroRNA Biomarkers as Promising Tools for Early Colorectal Cancer Screening-A Comprehensive Review.

Journal: International journal of molecular sciences

Published: June 09, 2023

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.

Syndecan-4 is a maestro of gastric cancer cell invasion and communication that underscores poor survival.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 08, 2023

The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes.

The Impact of BDNF, NTRK2, NGFR, CREB1, GSK3B, AKT, MAPK1, MTOR, PTEN, ARC, and SYN1 Genetic Polymorphisms in Antidepressant Treatment Response Phenotypes.

Journal: International journal of molecular sciences

Published: March 03, 2023

Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients.

Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients.

Journal: Cells

Published: December 30, 2021

Showing 1-12 of 42

Last Updated: 09/26/2026